Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Essence (BIOE) Equity Ratio (2020 - 2025)

Bio Essence has reported Equity Ratio over the past 6 years, most recently at 4.91 for Q4 2025.

  • For Q4 2025, Equity Ratio rose 53.56% year-over-year to 4.91; the TTM value through Dec 2025 reached 4.91, up 53.56%, while the annual FY2025 figure was 4.91, 53.56% up from the prior year.
  • Equity Ratio for Q4 2025 was 4.91 at Bio Essence, up from 16.81 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.6 in Q4 2023 and troughed at 27.64 in Q2 2025.
  • A 5-year average of 4.54 and a median of 1.57 in 2022 define the central range for Equity Ratio.
  • Biggest five-year swings in Equity Ratio: soared 71.24% in 2023 and later tumbled 3225.33% in 2025.
  • Year by year, Equity Ratio stood at 1.43 in 2021, then tumbled by 46.39% to 2.09 in 2022, then soared by 71.24% to 0.6 in 2023, then tumbled by 1655.42% to 10.57 in 2024, then soared by 53.56% to 4.91 in 2025.
  • Business Quant data shows Equity Ratio for BIOE at 4.91 in Q4 2025, 16.81 in Q3 2025, and 27.64 in Q2 2025.